Literature DB >> 16458429

Methyl protodioscin induces G2/M cell cycle arrest and apoptosis in HepG2 liver cancer cells.

Guanghui Wang1, Haifeng Chen, Minghui Huang, Naili Wang, Jinchao Zhang, Yaou Zhang, Ganrong Bai, Wang-Fun Fong, Mengsu Yang, Xinsheng Yao.   

Abstract

Methyl protodioscin (NSC-698790) is one of the main bioactive components in the traditional Chinese medicine Dioscorea collettii var. hypoglauca (Dioscoreaceae). In this study, we investigated the anti-proliferative effect of methyl protodioscin on the HepG2 cells and the mechanism of the induced cytotoxicity. Treatment of methyl protodioscin resulted in G2/M arrest and apoptosis in HepG2 cells. These effects were attributed to down-regulation of Cyclin B1 and the signaling pathways leading to up-regulation of Bax and down-regulation of BCL2, suggesting that methyl protodioscin may be a novel anti-mitotic agent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16458429     DOI: 10.1016/j.canlet.2005.10.050

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  20 in total

1.  Cardamonin, a natural chalcone, reduces 5-fluorouracil resistance of gastric cancer cells through targeting Wnt/β-catenin signal pathway.

Authors:  Gaochao Hou; Xiang Yuan; Yi Li; Gaoyu Hou; Xianli Liu
Journal:  Invest New Drugs       Date:  2019-05-17       Impact factor: 3.850

2.  B1, a novel naphthalimide-based DNA intercalator, induces cell cycle arrest and apoptosis in HeLa cells via p53 activation.

Authors:  Xin Liang; Aibin Wu; Yufang Xu; Ke Xu; Jianwen Liu; Xuhong Qian
Journal:  Invest New Drugs       Date:  2010-02-24       Impact factor: 3.850

3.  Cathepsin L suppression increases the radiosensitivity of human glioma U251 cells via G2/M cell cycle arrest and DNA damage.

Authors:  Qing-qing Zhang; Wen-juan Wang; Jun Li; Neng Yang; Gang Chen; Zhong Wang; Zhong-qin Liang
Journal:  Acta Pharmacol Sin       Date:  2015-06-22       Impact factor: 6.150

4.  The distribution of saponins in vivo affects their synergy with chimeric toxins against tumours expressing human epidermal growth factor receptors in mice.

Authors:  C Bachran; A Weng; D Bachran; S B Riese; N Schellmann; M F Melzig; H Fuchs
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

5.  Saponins as cytotoxic agents: a review.

Authors:  Irma Podolak; Agnieszka Galanty; Danuta Sobolewska
Journal:  Phytochem Rev       Date:  2010-06-25       Impact factor: 5.374

6.  A new quantitation method of protodioscin by HPLC-ESI-MS/MS in rat plasma and its application to the pharmacokinetic study.

Authors:  Xinxin Zhang; Zengjun Guo; Jing Li; Yoichiro Ito; Wenji Sun
Journal:  Steroids       Date:  2015-12-17       Impact factor: 2.668

7.  Cytotoxic activity of standardized extracts, a fraction, and individual secondary metabolites from fenugreek seeds against SKOV-3, HeLa and MOLT-4 cell lines.

Authors:  Justyna Stefanowicz-Hajduk; Barbara Król-Kogus; Barbara Sparzak-Stefanowska; Katarzyna Kimel; J Renata Ochocka; Mirosława Krauze-Baranowska
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

8.  Effects of Wild Yam Root (Dioscorea villosa) Extract on the Gene Expression Profile of Triple-negative Breast Cancer Cells.

Authors:  Elizabeth Mazzio; Abdulaziz Almalki; Selina F Darling-Reed; Karam F A Soliman
Journal:  Cancer Genomics Proteomics       Date:  2021 Nov-Dec       Impact factor: 4.069

9.  Methyl Protodioscin from the Roots of Asparagus cochinchinensis Attenuates Airway Inflammation by Inhibiting Cytokine Production.

Authors:  Ju Hee Lee; Hun Jai Lim; Chan Woo Lee; Kun-Ho Son; Jong-Keun Son; Sang Kook Lee; Hyun Pyo Kim
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-25       Impact factor: 2.629

10.  Development of a fluorescence polarization based high-throughput assay to identify Casitas B-lineage lymphoma RING domain regulators.

Authors:  Xingliang Xie; Lin Sun; Ziyan Yuan Pessetto; Yan Zhao; Zhihe Zang; Ling Zhong; Min Wu; Qing Su; Xiurong Gao; Wang Zan; Yiyi Sun
Journal:  PLoS One       Date:  2013-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.